BAIRD 2026 GLOBAL INDUSTRIAL CONFERENCE - FORTIVE CORP

Financial Performance:

• Annual revenue approx. $4.4 billion with 50% recurring revenue models.
• Gross margins approximately 63%; adjusted EBITDA margins around 30%.
• Generates over $1 billion in annual free cash flow with adjusted net income to free cash flow conversion exceeding 100%.
• Stock repurchased $2.3 billion over 18 months (approx. 13% of fully diluted shares).
• Pricing power remains robust, with annualized price increases in the 200 basis point range without evidence of fatigue.
• Core order growth accelerated to 7.2% in Q3, leading to a full-year core growth guidance raise to 5%.

Guidance and Future Outlook:

• Management expressed high confidence in the "40th Accelerator Strategy," targeting 50-100 basis points of annual adjusted EBITDA margin expansion over the medium term.
• Anticipates sustained, broad-based growth through 2027 driven by volume, pricing, and innovation rather than solely macro tailwinds.
• Expects the Advanced Health Solutions (AHS) segment to accelerate growth, potentially outpacing the current low single-digit run rate over the next decade.
• Margins are managed within defined guardrails; further expansion depends on reinvesting excess cash into high-growth opportunities and operating leverage from the Fortive Business System (FBS).

Business Segments and Product Lines:

• Intelligent Operating Solutions (IOS): Represents 70% of revenue; Fluke leads with 17 consecutive quarters of core order growth.
  • Fluke: Driving growth in data centers via new product introductions (e.g., CertiFiber Max) and specialized commercial capacity; product demand exceeds current capacity, prompting capacity doubling.
  • Facilities and Asset Lifecycle (FAL): Service Channel and Gordian are top performers; integration of AI tools (e.g., Flash AI) extending contract terms and enabling upsells.
• Advanced Health Solutions (AHS): Represents 30% of revenue; growth driven by healthcare consumables, capital equipment recovery, and Provation.
  • Provation: Expanding beyond GI into orthopedics, ENT, and gynecology; leveraging AI-powered voice documentation and deep proprietary data (30 years) to drive loyalty.
• Accurant: Undergoing product and commercial focus shifts; product set deemed compelling, with the next phase focused on commercial scaling to reflect in P&L.
• Software portfolio includes proprietary data, regulatory lock-in, and two-sided network effects, creating high stickiness and defensibility.

Market and Competitive Landscape:

• Growth vectors identified as data centers (hyperscalers), AI integration in industrial software, and shifting healthcare procedures to ambulatory surgical centers (ASCs).
• Data center demand is viewed as durable, driven by operations, maintenance, and lifecycle management rather than just new construction build-outs.
• Competitive advantage derived from "system of record/action" attributes and regulatory approvals that prevent easy substitution by generic AI solutions.
• Market trends favor industrial-like workflows in healthcare and high-trust professional instrumentation.

Risks and Challenges:

• Capacity constraints on high-demand products like CertiFiber Max, requiring continued ramp-up to meet excess demand.
• Macroeconomic uncertainty, though management notes the business model is resilient across build and operation phases.
• High hurdle rate for M&A, as stock repurchases currently offer a more attractive capital allocation return than most acquisition targets.
• Execution risk in scaling the commercial engine for the Accurant improvement journey.

Management Commentary and Tone:

• Tone is highly confident and optimistic, describing the company as being in the "early stages" of a decade-long growth story.
• Management emphasizes a "perpetual motion machine" of disciplined capital allocation, reinvestment, and margin expansion.
• Strong emphasis on execution, citing five consecutive quarters of beating expectations.
• CEO highlighted the dual-speed engine (IOS growth vs. AHS upside) as a strategic asset.

Analyst Questions and Answers:

• Growth Drivers: Confirmed broad-based acceleration across all three IOS elements (Fluke, FAL, Gas Detection) and AHS.
• Data Center Exposure: Clarified that Fluke's value proposition is tied to technician throughput and lifecycle maintenance, providing durability even if construction slows.
• AI Strategy: Detailed internal AI implementation (Center of Excellence established 7 years ago) focusing on customer product enhancements and internal R&D/CX workflows to boost productivity without significant cost increases.
• M&A Stance: Reiterated focus on bolt-on acquisitions that fit the existing platform and can be immediately accelerated, rather than large transformative deals.

Other Key Points:

• New product innovation pace at Fluke is significantly faster than historical averages, supporting future pricing power.
• Service Channel operates as a two-sided network connecting facility owners with maintenance technicians, enhancing defensibility.
• Management plans to continue disciplined capital allocation, balancing reinvestment for growth with returning capital to shareholders via buybacks.
• The "40th Accelerator Strategy" priorities include accelerating organic growth, disciplined capital allocation, and rebuilding investor trust.